Zydus, Formycon sign licensing deal for Keytruda biosimilar in US, Canada (Soban News)

Zydus will commercialise FYB206 in North America, while Formycon will lead development, regulatory filings and supply, with a US FDA filing expected soon​Zydus will commercialise FYB206 in North America, while Formycon will lead development, regulatory filings and supply, with a US FDA filing expected soon ​Latest News [ SOBAN NEWS: International and National ]